RHBC
TDOC icon

R.H. Bluestein & Co’s Teladoc Health TDOC Stock Holding History

R.H. Bluestein & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,000
Closed -$289K – 401
2022
Q1 		$289K Sell
4,000
-1,296
-24% -$93.4K 0.01% 303
2021
Q4 		$486K Sell
5,296
-200
-4% -$23.9K 0.02% 220
2021
Q3 		$697K Buy
5,496
+5
+0.1% +$728 0.03% 165
2021
Q2 		$913K Sell
5,491
-165
-3% -$26.7K 0.04% 139
2021
Q1 		$1.03M Sell
5,656
-886
-14% -$206K 0.04% 102
2020
Q4 		$1.31M Buy
6,542
+2,642
+68% +$537K 0.06% 87
2020
Q3 		$855K Sell
3,900
-580
-13% -$123K 0.04% 105
2020
Q2 		$855K Buy
4,480
+430
+11% +$75.4K 0.05% 104
2020
Q1 		$628K Sell
4,050
-3,060
-43% -$356K 0.05% 100
2019
Q4 		$595K Sell
7,110
-5,000
-41% -$381K 0.03% 136
2019
Q3 		$820K Buy
12,110
+800
+7% +$52.7K 0.05% 89
2019
Q2 		$751K Buy
11,310
+4,105
+57% +$239K 0.04% 95
2019
Q1 		$401K Buy
7,205
+2,100
+41% +$128K 0.02% 165
2018
Q4 		$253K Sell
5,105
-289,764
-98% -$17.7M 0.02% 220
2018
Q3 		$25.5M Buy
294,869
+271,569
+1,166% +$19.4M 1.23% 37
2018
Q2 		$1.35M Buy
23,300
+13,300
+133% +$650K 0.07% 59
2018
Q1 		$403K Hold
10,000
– – 0.02% 190
2017
Q4 		$349K Hold
10,000
– – 0.02% 220
2017
Q3 		$332K Buy
+10,000
New +$328K 0.02% 235

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

R.H. Bluestein & Co's TDOC Position: Q2 2022 in Review

R.H. Bluestein & Co sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,000 shares — an estimated $289K sold.

R.H. Bluestein & Co first reported a position in TDOC in Q3 2017 and held it in 19 quarters. The position peaked at $25.5M in Q3 2018. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • R.H. Bluestein & Co reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 4,000 Teladoc Health shares in Q2 2022, an estimated $289K.
  • R.H. Bluestein & Co first reported a position in Teladoc Health in Q3 2017 and held it in 19 quarters.
  • R.H. Bluestein & Co's Teladoc Health position peaked at $25.5M in Q3 2018.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.